121 related articles for article (PubMed ID: 7724247)
1. [In vitro antibacterial activity of cefpirome: a new cephalosporin; results of a multicenter study].
Soussy CJ; Chanal M; Derlot E; Goldstein F; Duval J
Pathol Biol (Paris); 1994 Oct; 42(8):754-60. PubMed ID: 7724247
[TBL] [Abstract][Full Text] [Related]
2. [In vitro antibacterial activity of a new oral cephalosporin, ceftibuten. Results of a multicenter study].
Soussy CJ; Meyran M; Chanal M; Reverdy ME; Kitzis MD; Derlot E
Pathol Biol (Paris); 1991 May; 39(5):396-402. PubMed ID: 1909017
[TBL] [Abstract][Full Text] [Related]
3. The in vitro activity and beta-lactamase stability of cefpirome (HR 810), a pyridine cephalosporin agent active against staphylococci, Enterobacteriaceae and Pseudomonas aeruginosa.
Neu HC; Chin NX; Labthavikul P
Infection; 1985; 13(3):146-55. PubMed ID: 3928497
[TBL] [Abstract][Full Text] [Related]
4. In-vitro antibacterial activity of cefepime: a multicentre study.
Duval J; Soussy CJ; Acar JF; Bergogne-Bérézin E; Cluzel R; Thabaut A; Courvalin P; Grès JJ; Rollin C
J Antimicrob Chemother; 1993 Nov; 32 Suppl B():55-61. PubMed ID: 8150767
[TBL] [Abstract][Full Text] [Related]
5. The antimicrobial activity and beta-lactamase stability of cefpirome, a new fourth-generation cephalosporin in comparison with other agents.
Cheng AF; Ling TK; Lam AW; Fung KS; Wise R
J Antimicrob Chemother; 1993 May; 31(5):699-709. PubMed ID: 8335498
[TBL] [Abstract][Full Text] [Related]
6. [Antibacterial effect of cefixime].
Soussy CJ; Meyran M; Duval J
Presse Med; 1989 Oct; 18(32):1546-50. PubMed ID: 2530528
[TBL] [Abstract][Full Text] [Related]
7. [In vitro antibacterial activity of RU 51746 (sodium salt of cefpodoxime). Results of a multicenter study].
Soussy CJ; Le Van Thoi J; Kitzis MD; Chanal C; Mounier M; Derlot E; Vergnaud M
Pathol Biol (Paris); 1990 May; 38(5):336-42. PubMed ID: 2195445
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro activity of cefpirome and cefepime, two new cephalosporins.
King A; Boothman C; Phillips I
Eur J Clin Microbiol Infect Dis; 1990 Sep; 9(9):677-85. PubMed ID: 2226498
[TBL] [Abstract][Full Text] [Related]
9. In vitro antibacterial activities of FK037: a new parenteral cephalosporin.
Inoue K; Inoue E; Mitsuhashi S
Chemotherapy; 1995; 41(4):257-66. PubMed ID: 7555206
[TBL] [Abstract][Full Text] [Related]
10. [A comparative study of antibacterial activity of ceftibuten, ceftazidime, cefuroxime and ampicillin against clinical isolates].
Ergova R; K'oleian E; Kharalambieva Ia; Mitov I; Docheva Iu
Vutr Boles; 2000; 32(1):13-7. PubMed ID: 11195191
[TBL] [Abstract][Full Text] [Related]
11. [In vitro antibacterial effect of a new oral cephalosporin, cefixime. Results of a multicenter study].
Soussy CJ; Kitzis MD; Thabaut A; Chanal M; Bure A; Vergnaud M; Reynaud AE; Coulet M; Dabernat H; Muller-Serieys C
Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):528-33. PubMed ID: 2508039
[TBL] [Abstract][Full Text] [Related]
12. The activity of cefpirome and ten other antibacterial agents against 2858 clinical isolates collected from 20 centres.
Reeves DS; Bywater MJ; Holt HA
J Antimicrob Chemother; 1993 Mar; 31(3):345-62. PubMed ID: 8486569
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activity of E-1040, a novel thiadiazolyl cephalosporin compared with other parenteral cephems.
Jones RN; Erwin ME; Barrett MS; Johnson DM; Briggs BM
Diagn Microbiol Infect Dis; 1991; 14(4):301-9. PubMed ID: 1889181
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of cefpirome against microorganisms isolated in haematology, oncology and intensive care units in Switzerland.
Liassine N; Bille J; Breer C; Frei R; Wüst J; Auckenthaler R
Scand J Infect Dis; 1997; 29(6):615-21. PubMed ID: 9571744
[TBL] [Abstract][Full Text] [Related]
15. In vitro antibacterial activity of FK037, a novel parenteral broad-spectrum cephalosporin.
Mine Y; Watanabe Y; Sakamoto H; Hatano K; Kuno K; Higashi Y; Kamimura T; Matsumoto Y; Tawara S; Matsumoto F
J Antibiot (Tokyo); 1993 Jan; 46(1):71-87. PubMed ID: 8436562
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
[TBL] [Abstract][Full Text] [Related]
17. In-vitro antimicrobial activity of Cefpirome: a new fourth-generation cephalosporin against clinically significant bacteria.
Hafeez S; Izhar M; Ahmed A; Zafar A; Naeem M
J Pak Med Assoc; 2000 Aug; 50(8):250-2. PubMed ID: 10992706
[TBL] [Abstract][Full Text] [Related]
18. The in-vitro activity of cefodizime: a review.
Soussy CJ; Chanal M; Kitzis MD
J Antimicrob Chemother; 1990 Nov; 26 Suppl C():13-21. PubMed ID: 2074248
[TBL] [Abstract][Full Text] [Related]
19. [In vitro antibacterial activity of a new cephalosporin: cefpirome (HR 810). Comparison with ceftriaxone, cefotaxime, latamoxef and ceftazidime].
Le Noc P; Bryskier A; Le Noc D
Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):567-71. PubMed ID: 3534744
[TBL] [Abstract][Full Text] [Related]
20. [In vitro activity of imipenem against hospital bacteria].
Soussy CJ; Duval J
Presse Med; 1990 Apr; 19(13):583-7. PubMed ID: 2139936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]